Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

Seroprevalence of fecal-oral transmitted hepatitis A and E virus antibodies in Burkina Faso.

Traoré KA, Rouamba H, Nébié Y, Sanou M, Traoré AS, Barro N, Roques P.

PLoS One. 2012;7(10):e48125. doi: 10.1371/journal.pone.0048125. Epub 2012 Oct 22.

2.

Hepatitis E virus infection in selected Brazilian populations.

Trinta KS, Liberto MI, de Paula VS, Yoshida CF, Gaspar AM.

Mem Inst Oswaldo Cruz. 2001 Jan;96(1):25-9.

3.

Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study.

Mohebbi SR, Rostami Nejad M, Tahaei SM, Pourhoseingholi MA, Habibi M, Azimzadeh P, Naghoosi H, Karayiannis P, Zali MR.

Trans R Soc Trop Med Hyg. 2012 Sep;106(9):528-31. doi: 10.1016/j.trstmh.2012.05.013. Epub 2012 Jul 24.

PMID:
22835757
4.

Prevalence of Hepatitis A virus (HAV) and Hepatitis E virus (HEV) in the patients presenting with acute viral hepatitis.

Joon A, Rao P, Shenoy SM, Baliga S.

Indian J Med Microbiol. 2015 Feb;33 Suppl:102-5. doi: 10.4103/0255-0857.150908.

5.

Coexistence of IgM antihepatitis A virus and IgM antihepatitis E virus in acute viral hepatitis: a prospective, multicentre study in Korea.

Jang JH, Jung YM, Kim JS, Lee SH, Kim JW, Hwang SG, Rim KS, Park SJ, Park YM, Kang SK, Lee HS, Yun H, Kim JH, Jeong SH.

J Viral Hepat. 2011 Oct;18(10):e408-14. doi: 10.1111/j.1365-2893.2011.01477.x. Epub 2011 Jun 1.

PMID:
21914057
6.

[Detection of anti-HAV IgM and anti-HEV IgM in patients with sporadic acute hepatitis in Beijing between 1995-2000].

Lu J, Zhao H, Mong Q.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2001 Jun;15(2):157-9. Chinese.

PMID:
11436647
7.

Swine is a possible source of hepatitis E virus infection by comparative study of hepatitis A and E seroprevalence in Thailand.

Sa-nguanmoo P, Posuwan N, Vichaiwattana P, Wutthiratkowit N, Owatanapanich S, Wasitthankasem R, Thongmee T, Poovorawan K, Theamboonlers A, Vongpunsawad S, Poovorawan Y.

PLoS One. 2015 Apr 30;10(4):e0126184. doi: 10.1371/journal.pone.0126184. eCollection 2015.

8.

Seroprevalence for hepatitis E virus (HEV) infection among volunteer blood donors of the Regional Blood Bank of Londrina, State of Paraná , Brazil.

Bortoliero AL, Bonametti AM, Morimoto HK, Matsuo T, Reiche EM.

Rev Inst Med Trop Sao Paulo. 2006 Mar-Apr;48(2):87-92. Epub 2006 May 8.

9.

Hepatitis E virus infection in haemodialysis patients: a case-control study in Saudi Arabia.

Ayoola EA, Want MA, Gadour MO, Al-Hazmi MH, Hamza MK.

J Med Virol. 2002 Mar;66(3):329-34.

PMID:
11793384
10.

Epidemiology of hepatitis A and hepatitis E infection and their determinants in adult Chinese community in Hong Kong.

Wong KH, Liu YM, Ng PS, Young BW, Lee SS.

J Med Virol. 2004 Apr;72(4):538-44.

PMID:
14981755
11.

Hepatitis A and E seroprevalence and associated risk factors: a community-based cross-sectional survey in rural Amazonia.

Vitral CL, da Silva-Nunes M, Pinto MA, de Oliveira JM, Gaspar AM, Pereira RC, Ferreira MU.

BMC Infect Dis. 2014 Aug 23;14:458. doi: 10.1186/1471-2334-14-458.

12.

[Hepatitis A and hepatitis E seroprevalence in adults in the Ankara area].

Cesur S, Akin K, Doğaroğlu I, Birengel S, Balik I.

Mikrobiyol Bul. 2002 Jan;36(1):79-83. Turkish.

PMID:
12476770
13.

[Hepatitis A and E virus antibodies in Chilean children of low socioeconomic status: a one year follow-up study].

Ibarra H, Riedemann S, Toledo C.

Rev Med Chil. 2006 Feb;134(2):139-44. Epub 2006 Mar 17. Spanish.

14.

[Seroprevalence and risk factors of hepatitis E among pregnant women in central Tunisia].

Hannachi N, Hidar S, Harrabi I, Mhalla S, Marzouk M, Ghzel H, Ghannem H, Khairi H, Boukadida J.

Pathol Biol (Paris). 2011 Oct;59(5):e115-8. doi: 10.1016/j.patbio.2009.06.004. Epub 2009 Nov 5. French.

PMID:
19896306
15.

Anti-hepatitis E virus antibody prevalence in French expatriate workers.

Vernier M, Rossi-Tamisier M, Richet H, Brouqui P, Parola P, Bouamri Y, Colson P, Gautret P.

Int J Infect Dis. 2013 Nov;17(11):e1082-4. doi: 10.1016/j.ijid.2013.06.013. Epub 2013 Aug 14.

16.

Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients.

Rossi-Tamisier M, Moal V, Gerolami R, Colson P.

J Clin Virol. 2013 Jan;56(1):62-4. doi: 10.1016/j.jcv.2012.09.010. Epub 2012 Oct 23.

PMID:
23089569
17.

Seroprevalence of anti-HEV IgG in 182 Polish patients.

Bura M, Michalak M, Chojnicki M, Czajka A, Kowala-Piaskowska A, Mozer-Lisewska I.

Postepy Hig Med Dosw (Online). 2015 Mar 8;69:320-6. doi: 10.5604/17322693.1143051.

18.

Population seroprevalence of hepatitis E virus antibodies in rural Bangladesh.

Labrique AB, Zaman K, Hossain Z, Saha P, Yunus M, Hossain A, Ticehurst J, Nelson KE.

Am J Trop Med Hyg. 2009 Nov;81(5):875-81. doi: 10.4269/ajtmh.2009.09-0352.

19.

Seroepidemiological study of hepatitis E virus infection in Japan using a newly developed antibody assay.

Tanaka E, Takeda N, Tian-Chen L, Orii K, Ichijo T, Matsumoto A, Yoshizawa K, Iijima T, Takayama T, Miyamura T, Kiyosawa K.

J Gastroenterol. 2001 May;36(5):317-21.

PMID:
11388394
20.

[Investigation of the hepatitis E virus seroprevalence in cases admitted to Hacettepe University Medical Faculty Hospital].

Aydın NN, Ergünay K, Karagül A, Pınar A, Us D.

Mikrobiyol Bul. 2015 Oct;49(4):554-64. Turkish.

PMID:
26649413
Items per page

Supplemental Content

Write to the Help Desk